209 related articles for article (PubMed ID: 27393618)
1. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
[TBL] [Abstract][Full Text] [Related]
2. Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers.
Manzano RG; Martinez-Navarro EM; Forteza J; Brugarolas A
Int J Oncol; 2014 Dec; 45(6):2250-66. PubMed ID: 25201346
[TBL] [Abstract][Full Text] [Related]
3. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells.
Ratsada P; Hijiya N; Hidano S; Tsukamoto Y; Nakada C; Uchida T; Kobayashi T; Moriyama M
Biochem Biophys Res Commun; 2020 Jul; 528(3):586-593. PubMed ID: 32505357
[TBL] [Abstract][Full Text] [Related]
4. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M
Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975
[TBL] [Abstract][Full Text] [Related]
6. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH
Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655
[TBL] [Abstract][Full Text] [Related]
7. Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer.
Hanna A; Nixon MJ; Estrada MV; Sanchez V; Sheng Q; Opalenik SR; Toren AL; Bauer J; Owens P; Mason FM; Cook RS; Sanders ME; Arteaga CL; Balko JM
Breast Cancer Res; 2022 Jul; 24(1):51. PubMed ID: 35850776
[TBL] [Abstract][Full Text] [Related]
8. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5.
Echavarria R; Hussain SN
J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939
[TBL] [Abstract][Full Text] [Related]
9. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
Xu X; Gao F; Wang J; Tao L; Ye J; Ding L; Ji W; Chen X
Cancer Biol Ther; 2018 May; 19(5):427-435. PubMed ID: 29509059
[TBL] [Abstract][Full Text] [Related]
10. The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression.
Mazumdar A; Tahaney WM; Reddy Bollu L; Poage G; Hill J; Zhang Y; Mills GB; Brown PH
NPJ Breast Cancer; 2019; 5():22. PubMed ID: 31372497
[TBL] [Abstract][Full Text] [Related]
11. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.
Zhang R; Wang G; Zhang PF; Zhang J; Huang YX; Lu YM; Da W; Sun Q; Zhu JS
J Cell Mol Med; 2017 Jun; 21(6):1117-1127. PubMed ID: 27957827
[TBL] [Abstract][Full Text] [Related]
12. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
[TBL] [Abstract][Full Text] [Related]
13. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
14. miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.
Hu N; Tian Y; Song Y; Zang L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760201
[TBL] [Abstract][Full Text] [Related]
15. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells.
Kamada H; Yasuhira S; Shibazaki M; Amano H; Maesawa C
J Invest Dermatol; 2022 Sep; 142(9):2499-2507.e6. PubMed ID: 35189148
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.
Britson JS; Barton F; Balko JM; Black EP
Biochem Biophys Res Commun; 2009 Dec; 390(3):849-54. PubMed ID: 19836351
[TBL] [Abstract][Full Text] [Related]
17. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner.
Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J
Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
[TBL] [Abstract][Full Text] [Related]
19. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition.
Gaggianesi M; Turdo A; Chinnici A; Lipari E; Apuzzo T; Benfante A; Sperduti I; Di Franco S; Meraviglia S; Lo Presti E; Dieli F; Caputo V; Militello G; Vieni S; Stassi G; Todaro M
Cancer Res; 2017 Jun; 77(12):3268-3279. PubMed ID: 28400477
[TBL] [Abstract][Full Text] [Related]
20. Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling.
Lin H; Qiu S; Xie L; Liu C; Sun S
Biomed Pharmacother; 2017 Aug; 92():340-346. PubMed ID: 28554129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
